Skip to content

Clinical trials

Phase 1 Hemorrhagic Fever, Ebola trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Fever, Ebola Phase: Phase 1 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20082
20101
20122
20143
20154
20171
20183
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)11
Arbutus Biopharma Corporation2
Sarepta Therapeutics, Inc.2
Albert B. Sabin Vaccine Institute1
Auro Vaccines LLC1
Cerus Corporation1
Inovio Pharmaceuticals1
International AIDS Vaccine Initiative1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Fever, Ebola20
Hemorrhagic Fevers, Viral5
Marburg Virus Disease3
Virus Diseases2
Acquired Immunodeficiency Syndrome1
Angioedemas, Hereditary1
Communicable Diseases1
Creutzfeldt-Jakob Syndrome1
Disseminated Intravascular Coagulation1
Filoviridae Infections1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.